Advertisement

Liver Cancers pp 295-307 | Cite as

Benign Liver Tumours

  • James Pape
  • Charles Imber
Chapter

Abstract

Benign liver tumours represent a significant proportion of the work of liver surgeons and hepatologists. Some of these are comparatively easy to manage, whilst others can be difficult to differentiate from malignant disease or have malignant potential, e.g. hepatocellular adenomas. This being the case, to have a body of professionals with experience in managing these, in particular experienced liver surgeons, physicians, radiologists and liver histopathologists, is vital to pursuing the right course of management and doing no harm, e.g. from unnecessary liver biopsies or surgical interventions. This chapter seeks to describe an approach to the management of the more common benign liver tumours including hepatocellular adenomas, haemangiomas, focal nodular hyperplasia and hepatic cysts.

Keywords

Hepatocellular adenoma Haemangioma Focal nodular hyperplasia Benign liver cysts 

References

  1. 1.
    Rooks JB, Ory HW, Ishak KG, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979;242:644–8.CrossRefGoogle Scholar
  2. 2.
    Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.CrossRefGoogle Scholar
  3. 3.
    Ronot M, Bahrami S, Calderaro J, et al. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology. 2011;53:1182–91.CrossRefGoogle Scholar
  4. 4.
    Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50:481–9.CrossRefGoogle Scholar
  5. 5.
    Tait N, Richardson AJ, Muguti G, Little JM. Hepatic cavernous haemangioma: a 10 year review. Aust N Z J Surg. 1992;62(7):521–4. http://www.ncbi.nlm.nih.gov/pubmed/1610320. [cited 2018 Jan 14]CrossRefGoogle Scholar
  6. 6.
    Leifer DM, Middleton WD, Teefey SA, Menias CO, Leahy JR. Follow-up of patients at low risk for hepatic malignancy with a characteristic hemangioma at US. Radiology. 2000;214(1):167–72. http://pubs.rsna.org/doi/10.1148/radiology.214.1.r00ja09167. [cited 2018 Jan 14]CrossRefGoogle Scholar
  7. 7.
    Miura JT, Amini A, Schmocker R, Nichols S, Sukato D, Winslow ER, et al. Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB. 2014;16(10):924–8. http://www.ncbi.nlm.nih.gov/pubmed/24946109. [cited 2018 Jan 14]CrossRefGoogle Scholar
  8. 8.
    Gaspar L, Mascarenhas F, da Costa MS, Dias JS, Afonso JG, Silvestre ME. Radiation therapy in the unresectable cavernous hemangioma of the liver. Radiother Oncol. 1993;29(1):45–50. http://www.ncbi.nlm.nih.gov/pubmed/8295987. [cited 2018 Jan 14]CrossRefGoogle Scholar
  9. 9.
    Ezekowitz RAB, Mulliken JB, Folkman J. Interferon Alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992;326(22):1456–63. http://www.ncbi.nlm.nih.gov/pubmed/1489383. [cited 2018 Jan 14]CrossRefGoogle Scholar
  10. 10.
    Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology. 1985;5(6):1194–200. http://www.ncbi.nlm.nih.gov/pubmed/4065824. [cited 2018 Jan 4]CrossRefGoogle Scholar
  11. 11.
    Nguyen BN, Fléjou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol. 1999;23(12):1441–54. http://www.ncbi.nlm.nih.gov/pubmed/10584697. [cited 2018 Jan 5]CrossRefGoogle Scholar
  12. 12.
    Luciani A, Kobeiter H, Maison P, Cherqui D, Zafrani E-S, Dhumeaux D, et al. Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? Gut. 2002;50(6):877–80. http://www.ncbi.nlm.nih.gov/pubmed/12010893. [cited 2018 Jan 5]CrossRefGoogle Scholar
  13. 13.
    Cristiano A, Dietrich A, Spina JC, Ardiles V, de Santibañes E. Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updates Surg. 2014;66(1):9–21. http://www.ncbi.nlm.nih.gov/pubmed/23807711. [cited 2018 Jan 3]CrossRefGoogle Scholar
  14. 14.
    Rogers JV, Mack LA, Freeny PC, Johnson ML, Sones PJ. Hepatic focal nodular hyperplasia: angiography, CT, sonography, and scintigraphy. AJR Am J Roentgenol. 1981;137(5):983–90. http://www.ajronline.org/doi/10.2214/ajr.137.5.983. [cited 2018 Jan 6]CrossRefGoogle Scholar
  15. 15.
    Vogt DP, Henderson JM, Chmielewski E. Cystadenoma and cystadenocarcinoma of the liver: a single center experience. J Am Coll Surg. 2005;200:727–33.CrossRefGoogle Scholar
  16. 16.
    Seo JK, Kim SH, Lee SH, et al. Appropriate diagnosis of biliary cystic tumors: comparison with atypical hepatic simple cysts. Eur J Gastroenterol Hepatol. 2010;22:989–96.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Centre For HPB Surgery and Liver TransplantationRoyal Free HospitalLondonUK

Personalised recommendations